Critical Minerals and Energy Intelligence

Gold, uranium, tungsten, graphite, other metals, exempted from US global tariffs with new Trump directive

Subscribe for Investment Insights. Stay Ahead.

Investment market and industry insights delivered to you in real-time.

[mepr-membership-registration-form id="4595"]

US president Donald Trump has issued a new executive order exempting gold bullion, uranium, tungsten, graphite, and several other metals from global tariffs, effective Monday, Sept 8. The order also imposes new tariffs on silicone products, resin, and aluminum hydroxide.

The exemption is part of a revision to the scope of reciprocal tariffs and procedures for implementing trade and security agreements. The Commerce Department and US Trade Representative are now authorized to adjust tariffs as part of framework agreements with countries such as the European Union, Japan, and South Korea, without requiring additional executive orders.

The European Union welcomed the exemptions, noting that they could lead to lower US auto tariffs and improved access to key minerals.

“I welcome the US EO as a crucial step in implementing the EU-US Joint Statement. It paves the way for car and parts tariffs to drop to 15% and secures key exemptions from the 15% cap” — Maros Sefcovic, EU’s Commissioner for Trade and Economic Security

However, the legal status of some tariffs remains unresolved, as court challenges continue.

Gold bullion was previously subject to confusion after a US Customs ruling suggested it would face import taxes. The new directive clarifies that gold, along with uranium and tungsten, will be imported tariff-free. These metals are considered critical for sectors including nuclear energy, aerospace, and advanced manufacturing, and are not produced in sufficient quantities in the US.

The executive order aims to facilitate trade agreements and secure supply chains for minerals and products that cannot be grown, mined, or manufactured domestically. Pharmaceuticals and certain minerals used in electronics and medical devices will also see relief from tariffs.

The changes reflect ongoing efforts by the US government to address trade imbalances and strengthen domestic manufacturing while ensuring access to strategic resources.

Disclaimer

The Oregon Group maintains full editorial control over all content published on this website. While sponsored and advertised placements may be featured, the content remains the sole opinion of The Oregon Group. The author may receive compensation or remuneration for providing content, but all statements and expressions are made independently and are not influenced by sponsors or advertisers. From time to time, The Oregon Group and its directors, officers, partners, employees, authors, or members of their families, as well as persons who are interviewed for articles on this website, may have a long or short position in securities or commodities mentioned and may make purchases and/or sales of those securities or commodities in the open market or otherwise. By accessing and using this website, readers are cautioned to assume that each of the foregoing persons may have a financial interest in all companies and sectors mentioned on this website. Any projections, market outlooks or estimates herein are forward looking statements and are inherently unreliable., and any such statements are based upon certain assumptions and should not be construed to be indicative of the actual events that will occur. Other events that were not taken into account may occur and may significantly affect the returns or performance of the securities or commodities discussed herein. The information provided herein is based on matters as they exist as of the date of preparation and not as of any future date, and The Oregon Group undertakes no obligation to correct, update or revise the information in this document or to otherwise provide any additional material. The information provided on this website is for informational purposes only and is not, directly or indirectly, an offer, solicitation of an offer and/or a recommendation to buy or sell any security or commodity, and the information provided on this website should not be construed as any advice or an opinion as to the price at which the securities of any company or commodity may trade at any time. The Oregon Group is a publisher of financial information, not an investment advisor. We do not provide personalized or individualized investment advice or information that is tailored to the needs of any particular recipient, and the information provided on this website is not and should not be construed as personal, financial, investment or professional advice. Readers are cautioned to always do their own research and review of publicly available information and to consult their professional and registered advisors before purchasing or selling any securities or commodities and should not rely on the information contained herein. Neither The Oregon Group nor any of its affiliates accepts any liability whatsoever for any direct or consequential loss howsoever arising, directly or indirectly, from any use of the information contained herein. By using the Site or any affiliated social media account, you are indicating your consent and agreement to this disclaimer and our terms of use. Unauthorized reproduction of this newsletter or its contents by photocopy, facsimile or any other means is illegal and punishable by law.